(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Startek to Review Takeover Bid; Bullish Stance on Ardelyx

  • August 25th, 2023
  • 245 views

Shares of Startek, Inc. (NYSE: SRT) surged in after-hours trading following the announcement of a special committee of independent directors to assess the non-binding proposal by CSP Management Limited, dated July 18, 2023, which suggests acquiring all the remaining shares of Startek at a rate of $3.80 in cash per share. 

CSP Management currently holds around 56% stake in Startek. Notably, the proposal from CSP indicates that it has no intentions of selling its interests in Startek or considering any collaboration or sale of assets to other potential parties.

$SRT was trading at $3.16 in after-hours, up $0.15 (+4.98%).

In other news, Ardelyx, Inc. (Nasdaq: ARDX), a pharmaceutical company, received a boost in investor sentiment as Cantor Fitzgerald upgraded the company from Neutral to Overweight and raised the price target from $5 to $10.

Considering that $ARDX closed at $3.94 on Friday, this revised price target indicates a potential upside of $6.06 or approximately 153.81%, based on the financial services firm's assessment.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13